Bone Marrow TransplantationBone MarrowTransplantation, AutologousBone Marrow CellsTransplantation, HomologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyGraft vs Host DiseaseCyclophosphamideBone and BonesWhole-Body IrradiationTreatment OutcomeLeukemiaAnemia, AplasticTransplantation ConditioningTissue DonorsAntineoplastic AgentsGraft SurvivalLymphoma, Non-HodgkinHematopoietic Stem CellsTransplantation ChimeraHistocompatibility TestingBone Marrow PurgingBone Marrow DiseasesBusulfanHistocompatibilityHematologic NeoplasmsLeukemia, Myeloid, AcuteImmunosuppressive AgentsTime FactorsBone Marrow ExaminationHematopoiesisRecurrenceBone RemodelingKidney TransplantationTransplantation, IsogeneicLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow NeoplasmsCytomegalovirus InfectionsLiver TransplantationRadiation ChimeraGraft RejectionImmunosuppressionSalvage TherapyChemotherapy, AdjuvantSurvival AnalysisAcute DiseaseLeukemia, MyeloidCyclosporineRetrospective StudiesHepatic Veno-Occlusive DiseaseBone DensityGraft vs Host ReactionLymphocyte DepletionRemission InductionHematologic DiseasesColony-Forming Units AssayMyelodysplastic SyndromesT-LymphocytesHLA AntigensSurvival RateOpportunistic InfectionsImmunocompromised HostDisease-Free SurvivalFatal OutcomeFollow-Up StudiesLeukocyte TransfusionNuclear FamilyBone ResorptionStem Cell TransplantationChimeraTransplantation ImmunologyCell DifferentiationSevere Combined ImmunodeficiencyHeart TransplantationLymphocyte TransfusionDose-Response Relationship, DrugActuarial AnalysisPrognosisLeukocyte CountBone NeoplasmsMultiple MyelomaFlow CytometryHodgkin DiseaseGranulocyte Colony-Stimulating FactorMethotrexateMice, Inbred BALB CLymphomaSpleenCells, CulturedEtoposideLung TransplantationPancytopeniaAntigens, CD34CytarabineInfection